Frank Lee
About Frank Lee
Frank Lee is a Quality Assurance Manager at Bristol Myers Squibb in Seattle, Washington, with a background in microbiology and biology.
Company
Frank Lee is currently employed at Bristol Myers Squibb, serving as a Quality Assurance Manager. The company is located in Seattle, Washington, United States. Bristol Myers Squibb is a global biopharmaceutical company known for its focus on innovation and commitment to discovering, developing, and delivering transformational medicines for patients across the globe.
Title
Frank Lee holds the position of Quality Assurance Manager at Bristol Myers Squibb. In this capacity, he oversees quality assurance initiatives, ensuring that products meet stringent regulatory and company standards. His role involves crucial responsibilities in maintaining the quality and compliance of pharmaceutical products.
Professional Background
Frank Lee has a rich professional background spanning various roles in the biopharmaceutical industry. He previously worked at Bristol Myers Squibb as a Senior Specialist, Engineer II for one year in Warren County, New Jersey. Before that, he served for three years as a Senior Clinical Manufacturing Associate specializing in CAR T therapies at Celgene in Warren, NJ. His earlier roles include a four-year tenure as a Scientist II, Manufacturing Support at Kashiv BioSciences LLC in Chicago and a two-month internship at JINIS Biopharmaceuticals Co. in South Korea.
Education and Expertise
Frank Lee has an extensive educational background in the life sciences. He earned a Professional Science Masters in Microbiology from Illinois Institute of Technology from 2013 to 2014. Prior to this, he obtained a Bachelor of Science degree in Biology from Purdue University, where he studied from 2005 to 2011. His academic credentials form a solid foundation for his expertise in the fields of microbiology and biology.
Achievements
Frank Lee successfully transitioned within a year from the role of Senior Specialist, Engineer II to Quality Assurance Manager at Bristol Myers Squibb. His notable experience includes working on CAR T cell therapy during his tenure at Celgene, contributing to advancements in this groundbreaking area of cancer treatment. Additionally, he played a significant role in manufacturing support as a Scientist II at Kashiv BioSciences LLC.